2017 annual financial data
Cartesian Therapeutics 2017 Operating margin
Direct answer
Operating margin was -30,813.53%.
Operating income was -63,784,000 USD and net income was -65,321,000 USD.
Operating cash flow was -52,037,000 USD.
Get free Cartesian Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 207,000 USD
- Operating income
- -63,784,000 USD
- Net income
- -65,321,000 USD
- Operating cash flow
- -52,037,000 USD